Neoadjuvant Treatment with Angiogenesis‐Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study

BACKGROUND: Hepatocellular carcinoma (HCC) recurrence rates following locoregional treatment are high. As multireceptor tyrosine kinase inhibitors targeting vascular endothelial growth factor receptors (VEGFRs) are effective in advanced HCC, we assessed the efficacy and safety of neoadjuvant systemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Woei‐A‐Jin, F.J. Sherida H., Weijl, Nir I., Burgmans, Mark C., Fariña Sarasqueta, Arantza, van Wezel, J. Tom, Wasser, Martin N.J.M., Coenraad, Minneke J., Burggraaf, Jacobus, Osanto, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488766/
https://www.ncbi.nlm.nih.gov/pubmed/34251745
http://dx.doi.org/10.1002/onco.13901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488766/
https://www.ncbi.nlm.nih.gov/pubmed/34251745
http://dx.doi.org/10.1002/onco.13901

Ejemplares similares